Variation in Trans-3′-Hydroxycotinine Glucuronidation Does Not Alter the Nicotine Metabolite Ratio or Nicotine Intake
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Variation in Trans-3′-Hydroxycotinine Glucuronidation Does Not Alter the Nicotine Metabolite Ratio or Nicotine Intake
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 8, Pages e70938
Publisher
Public Library of Science (PLoS)
Online
2013-08-03
DOI
10.1371/journal.pone.0070938
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex
- (2013) A. Z. X. Zhu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Reproducibility of the Nicotine Metabolite Ratio in Cigarette Smokers
- (2012) G. St.Helen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation
- (2012) Andy Z.X. Zhu et al. CARCINOGENESIS
- Glucuronidation of trans-3′-hydroxycotinine by UGT2B17 and UGT2B10
- (2012) Gang Chen et al. Pharmacogenetics and Genomics
- CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people
- (2012) Matthew J. Binnington et al. Pharmacogenetics and Genomics
- Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level
- (2011) A. A. Strasser et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Racial Differences in the Relationship Between Number of Cigarettes Smoked and Nicotine and Carcinogen Exposure
- (2011) N. L. Benowitz et al. NICOTINE & TOBACCO RESEARCH
- Urine Menthol as a Biomarker of Mentholated Cigarette Smoking
- (2010) N. L. Benowitz et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Glucuronidation Genotypes and Nicotine Metabolic Phenotypes: Importance of Functional UGT2B10 and UGT2B17 Polymorphisms
- (2010) G. Chen et al. CANCER RESEARCH
- Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended-Duration Transdermal Nicotine Therapy
- (2010) C Lerman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers
- (2009) MK Ho et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Nicotine Metabolism in African Americans and European Americans: Variation in Glucuronidation by Ethnicity and UGT2B10 Haplotype
- (2009) J. Z. Berg et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Genetic and environmental influences on the ratio of 3′hydroxycotinine to cotinine in plasma and urine
- (2009) Gary E. Swan et al. Pharmacogenetics and Genomics
- Genome-wide Copy-Number-Variation Study Identified a Susceptibility Gene, UGT2B17, for Osteoporosis
- (2008) Tie-Lin Yang et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Adaptive Evolution of UGT2B17 Copy-Number Variation
- (2008) Yali Xue et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Nicotine Metabolism in Three Ethnic/Racial Groups with Different Risks of Lung Cancer
- (2008) K. S. Derby et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion
- (2008) F Patterson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started